The US$38 million issuance, which took place on 11 November, will be used to finance investments in medical equipment, buildings, and the restructuring of the company’s financial liabilities.
According to Ferrere Abogados partner Diego Rodríguez, the most challenging aspect of the deal was “the preparation and submission for government approval of a major institutional restructuring plan to make it possible to obtain the guarantee.”